...
首页> 外文期刊>Rheumatology International >Polymorphonuclear leukocyte adhesion to articular cartilage is inhibited by cartilage surface macromolecules
【24h】

Polymorphonuclear leukocyte adhesion to articular cartilage is inhibited by cartilage surface macromolecules

机译:软骨表面大分子抑制多形核白细胞粘附于关节软骨

获取原文
获取原文并翻译 | 示例
           

摘要

The present studies deal with polymorphonuclear neutrophil (PMN) adhesion inhibitory properties of cartilage surface proteoglycans. Normal human PMN were used in adhesion experiments with bovine cartilage surfaces exposed to neutrophil elastase and reconstituted with fibronectin (Fn) or on plastic-bound Fn. An extract of cartilage surface small proteoglycans (SE) and purified fibromodulin (FM), decorin (DCN), biglycan (BGN), and aggrecan (AGN) on the surface of normal cartilage were used to test for inhibition of Fn-dependent cell adhesion. The PMN did not adhere to intact articular cartilage surfaces, whereas significant adhesion was measured using cartilage explants digested with elastase and reconstituted with Fn. Incubation of elastase-treated, Fn-reconstituted cartilage with 45 µg/ml SE inhibited PMN adhesion by 50.7±5.8% (P<0.0001). Addition of 50 µg/ml purified FM to the reconstituted articular surfaces inhibited cell adhesion by 71.2±13.9% (P<0.0001). Inhibition of PMN adhesion to plastic-bound Fn was seen with 1.7 µg/ml SE (20.4±8.0%). Maximal inhibition of 67.4±14.8% (P<0.01) was obtained with 17.0 µg/ml SE. With FM, concentrations of 4.3 µg/ml resulted in 34.7±25.2 inhibition (P<0.001), and maximal inhibition of 66.3±16.2% (P<0.01) was obtained with 43.0 µg/ml. Similar results were obtained with purified bovine DCN and BGN. The main component of cartilage matrix, AGN, failed to inhibit cell adhesion significantly. The results indicate that macromolecules normally present on articular cartilage surfaces act as a barrier to PMN adhesion. Since cartilage surface proteins are susceptible to breakdown by proteases from synovial fluid inflammatory cells, we postulate that the degradation of this barrier may be responsible for increasing PMN adhesion and subsequent cartilage damage in inflammatory arthritis.
机译:本研究涉及软骨表面蛋白聚糖的多形核中性粒细胞(PMN)粘附抑制特性。正常人PMN用于粘附实验,使牛软骨表面暴露于嗜中性粒细胞弹性蛋白酶并用纤连蛋白(Fn)或结合塑料的Fn重构。正常软骨表面的软骨表面小蛋白聚糖(SE)和纯化的纤维调节蛋白(FM),核心蛋白聚糖(DCN),双糖蛋白(BGN)和聚集蛋白聚糖(AGN)的提取物用于测试对Fn依赖性细胞粘附的抑制作用。 PMN不会粘附到完整的关节软骨表面,而使用弹性蛋白酶消化并用Fn重构的软骨外植体可测量到显着的粘附。用弹性酶处理的Fn重建的软骨与45μg/ ml的SE一起孵育抑制PMN粘附50.7±5.8%(P <0.0001)。向重建的关节表面添加50 µg / ml纯化的FM抑制细胞粘附71.2±13.9%(P <0.0001)。用1.7 µg / ml SE(20.4±8.0%)观察到PMN对塑料结合的Fn的抑制作用。使用17.0 µg / ml SE可获得67.4±14.8%的最大抑制(P <0.01)。使用FM时,浓度为4.3 µg / ml会产生34.7±25.2抑制(P <0.001),使用43.0 µg / ml时,最大抑制为66.3±16.2%(P <0.01)。使用纯化的牛DCN和BGN获得了相似的结果。软骨基质的主要成分AGN无法明显抑制细胞粘附。结果表明,通常存在于关节软骨表面的大分子充当PMN粘附的屏障。由于软骨表面蛋白易于被滑液炎性细胞中的蛋白酶分解,因此我们推测该屏障的降解可能是导致PMN粘附增加以及炎性关节炎中随后的软骨损伤的原因。

著录项

  • 来源
    《Rheumatology International》 |2001年第5期|180-185|共6页
  • 作者

    Y. Mitani; A. Honda; H. Jasin;

  • 作者单位

    Theresa Scheu Rheumatoid Arthritis Research Laboratory Mail Slot 509 Division of Rheumatology and Clinical Immunology University of Arkansas for Medical Science Department of Internal Medicine and John L. McClellan Veterans Administration Center Mail Slot 509 4301 West Markham Little Rock AR 72205 USA;

    Theresa Scheu Rheumatoid Arthritis Research Laboratory Mail Slot 509 Division of Rheumatology and Clinical Immunology University of Arkansas for Medical Science Department of Internal Medicine and John L. McClellan Veterans Administration Center Mail Slot 509 4301 West Markham Little Rock AR 72205 USA;

    Theresa Scheu Rheumatoid Arthritis Research Laboratory Mail Slot 509 Division of Rheumatology and Clinical Immunology University of Arkansas for Medical Science Department of Internal Medicine and John L. McClellan Veterans Administration Center Mail Slot 509 4301 West Markham Little Rock AR 72205 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Cell adhesion Articular cartilage Nitric oxide Polymorphonuclear neutrophils Fibronectin;

    机译:细胞粘附关节软骨一氧化氮多形核中性粒细胞纤连蛋白;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号